VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DMRADamora Therapeutics, Inc.
$22.56$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDMRACash Flow

Damora Therapeutics, Inc. (DMRA) Cash Flow Statement

8Y historyFree accessUpdated daily

Damora Therapeutics, Inc. (DMRA) annual cash flow statement — 8-year operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

DMRA Cash Flow Statement

Annual statement

DMRA Cash Flow Statement

Damora Therapeutics, Inc. (DMRA) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Cash from Operations-59.13M-6.73M-18.62M-36.91M-42.93M-52.31M-38.2M-19.33M-13.69M
Operating CF Margin %---------
Operating CF Growth %0%63.88%49.55%14.02%17.92%-36.92%-97.68%-41.16%-
Net Income-291.68M-209.84M-21.44M-38.35M-61.62M-51.75M-34.84M-36.51M-15.87M
Depreciation & Amortization91K34K181K830K490K441K188K111K0
Stock-Based Compensation8.02M998K0000000
Deferred Taxes000000000
Other Non-Cash Items192.17M183.72M5.3M4.98M6.26M5.63M1.04M14.88M3.11M
Working Capital Changes32.27M18.36M-2.67M-4.37M11.94M-6.62M-4.59M2.19M-933K
Change in Receivables000000000
Change in Inventory000000000
Change in Payables22.77M17.27M-1.32M-1.65M1.82M-1.32M-477K1.94M733K
Cash from Investing-196.13M-17.37M11.65M22.33M12.38M-48.05M0-326K0
Capital Expenditures0000-196K-223K000
CapEx % of Revenue---------
Acquisitions0-17.37M083K000-326K0
Investments---------
Other Investing750K00000000
Cash from Financing597.39M266.84M02.88M507K0187.39M042.87M
Debt Issued (Net)000000008.51M
Equity Issued (Net)597.39M266.81M02.88M507K0187.39M034.36M
Dividends Paid000000000
Share Repurchases000000000
Other Financing033K0000000
Net Change in Cash342.05M243.45M-7.29M-11.32M-29.78M-101.02M152.29M-19.69M30.99M
Free Cash Flow-59.13M-6.73M-18.62M-36.91M-43.13M-52.53M-38.2M-19.33M-13.69M
FCF Margin %---------
FCF Growth %-63.88%49.55%14.42%17.9%-37.5%-97.68%-41.16%-
FCF per Share-3.61-4.93-16.09-34.73-42.43-51.99-37.81-19.00-13.46
FCF Conversion (FCF/Net Income)0.20x0.03x0.87x0.96x0.70x1.01x1.10x0.53x0.86x
Interest Paid000000000
Taxes Paid05K0000000

DMRA — Frequently Asked Questions

Quick answers to the most common questions about buying DMRA stock.

How much cash does Damora Therapeutics, Inc. (DMRA) generate from operations?

Damora Therapeutics, Inc. (DMRA) generated $-6.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Damora Therapeutics, Inc.'s free cash flow?

Damora Therapeutics, Inc. (DMRA) reported negative free cash flow of $6.7M in 2025, indicating capital requirements exceeded cash from operations.

What is Damora Therapeutics, Inc.'s capital expenditure (CapEx)?

Damora Therapeutics, Inc. (DMRA) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.